Seamount Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Sell
4,607
-15
-0.3% -$1.21K 0.15% 102
2026
Q1
$400K Buy
4,622
+250
+6% +$23.9K 0.18% 99
2025
Q4
$420K Buy
4,372
+15
+0.3% +$1.46K 0.19% 95
2025
Q3
$415K Buy
4,357
+200
+5% +$18.4K 0.2% 96
2025
Q2
$362K Buy
+4,157
New +$353K 0.19% 97

Other funds holding MDT

Seamount Financial Group's MDT Position: Q2 2026 in Review

Seamount Financial Group reduced its Medtronic (MDT) stake by 0.32% in Q2 2026, selling an estimated $1.21K and leaving 4,607 shares worth $360K. The position accounts for 0.15% of the portfolio, ranked #102.

Seamount Financial Group first reported a position in MDT in Q2 2025 and has held it in 5 quarters since. The position peaked at $420K in Q4 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Seamount Financial Group held 4,607 shares of Medtronic worth $360K as of Q2 2026.
  • Seamount Financial Group sold 15 Medtronic shares in Q2 2026, an estimated $1.21K.
  • Medtronic made up 0.15% of Seamount Financial Group's portfolio in Q2 2026, its #102 holding.
  • Seamount Financial Group first reported a position in Medtronic in Q2 2025 and has held it in 5 quarters since.
  • Seamount Financial Group's Medtronic position peaked at $420K in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Seamount Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.